| Literature DB >> 29985436 |
Eriko Kitahara1, Yasushi Shimo2, Hideo Mori2, Masanori Nagaoka3.
Abstract
While motor learning approaches are effective in rehabilitating Parkinson's disease (PD) patients, many studies reported deficits in sequential motor learning in these patients. We hypothesised that preserved explicit learning of visuomotor sequences in PD patients contributed to the effectiveness of motor learning approaches. However, there are very few studies analysing explicit learning of visuomotor sequences during the progression of PD. We investigated this phenomenon in 23 patients with moderate to severe PD (Hoehn-Yahr stages II-IV) and 17 age-matched controls using sequential button-press tasks (2 × 5 task). We found (1) no significant differences in numbers of errors in the 2 × 5 task among control and PD groups. (2) There was a significant difference in response times while exploring correct sequences (ERT) among control and PD groups; ERTs in stage-IV patients tended to be longer than those of control and stage-II groups. (3) All four groups significantly improved their performance (i.e., reduced ERTs in the 2 × 5 task) with sequence repetition, although stage-III:IV patients were slower. Thus, even patients with severe PD can learn visual sequences and can translate them into visuomotor sequences (explicit visuomotor sequence learning), albeit slower than controls, providing evidence for effective motor learning approaches during rehabilitation of patients with advanced PD.Entities:
Mesh:
Year: 2018 PMID: 29985436 PMCID: PMC6037724 DOI: 10.1038/s41598-018-28640-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Procedure and outcome measures (a) Procedure for the 2 × 5 task. For correct responses, participants were asked to first press the button indicated by a “1” in each set, followed by the one marked “2”. (b) Procedure of the random task and 1 × 10 task. (c) Number of completed sets in the 2 × 5 task. The performance of a representative patient with stage IV PD. (d) The average of ERTs in the 2 × 5 task. These data were obtained by the same patient shown in (c). Grey triangles indicate the average ERT in each trial. Black dots indicate the average ERT in successful trials.
Participant demographics.
| Characteristic | PD patients | Controls | F | P | Test used | ||
|---|---|---|---|---|---|---|---|
| Stage II | Stage III | Stage IV | (n = 17) | ||||
| Gender (M/F) | 5/3 | 5/5 | 2/3 | 10/7 | |||
| Age (years) | 63.2 ± 5.5 | 62.8 ± 7.2 | 61.0 ± 8.5 | 63.2 ± 5.5 | 0.301 | 0.824 | ANOVA |
| MMSE | 27.9 ± 1.5 | 28.3 ± 1.5 | 28.4 ± 1.5 | 28.6 ± 1.1 | 0.6 | KW | |
| Duration of PD (years) | 7.3 ± 4.5 | 7.3 ± 3.8 | 13.8 ± 9.6 | 0.19 | KW | ||
| UPDRS motor section | 14.4** ± 5.9 | 22.3* ± 8.9 | 35.4 ± 7.3 | 11.7 | <0.001 | ANOVA | |
| LLED (mg/day) | 437.5 ± 240.1 | 445.0 ± 231.5 | 550.0 ± 316.2 | 0.359 | 0.703 | ANOVA | |
Values are means ± SD. KW: Kruskal Wallis test. *P < 0.05 compared to Stage IV. **P < 0.01 compared to Stage IV.
Figure 2Motor speed in random task and errors and response time in the 2 × 5 task. (a) Motor speed in random task. (b) The number of errors in the 2 × 5 task for each group. (c) Early-ERT in the 2 × 5 task. (d) Early-SRT in the 2 × 5 task.
Figure 3Changes in RT during repeated trials in three tasks. (a) RT in the random task. (b) RT in the 1 × 10 task. (c) ERT in the 2 × 5 task. (d) SRT in the 2 × 5 task.
Results of one-sample t-test in beta values at the group level.
| PD stage | Beta values | Degree of freedom | t values | P |
|---|---|---|---|---|
|
| ||||
| Control | −22.34 ± 18.12 | 16 | −5.08 | <0.001** |
| Stage II | −8.20 ± 14.21 | 7 | −1.63 | 0.147 |
| Stage III | −3.33 ± 24.80 | 9 | −0.42 | 0.681 |
| Stage IV | −3.32 ± 27.56 | 4 | −0.27 | 0.801 |
| Control | −18.11 ± 20.51 | 16 | −3.64 | 0.002** |
| Stage II | −31.27 ± 22.32 | 7 | −3.96 | 0.005** |
| Stage III | −15.18 ± 33.40 | 9 | −1.44 | 0.185 |
| Stage IV | 6.80 ± 35.10 | 4 | 0.43 | 0.687 |
| Control | −104.08 ± 56.23 | 16 | −7.632 | <0.001** |
| Stage II | −108.22 ± 57.15 | 7 | −5.36 | 0.001** |
| Stage III | −155.04 ± 79.8 | 9 | −6.14 | <0.001** |
| Stage IV | −125.81 ± 82.66 | 4 | −3.403 | 0.027* |
| Control | −6.36 ± 11.30 | 16 | −2.32 | 0.034* |
| Stage II | −4.26 ± 15.64 | 7 | −0.77 | 0.47 |
| Stage III | −12.64 ± 44.95 | 9 | −0.89 | 0.4 |
| Stage IV | 11.74 ± 30.04 | 4 | 0.87 | 0.432 |
Beta values are means ± SD. *P < 0.05 compared to zero, **P < 0.01 compared to zero.
Figure 4Correlation between number of errors and Early-ERT (a) Control group. (b) PD group.